Alopecia Areata Post-Alemtuzumab in MS
نُشرت في الجمعة، 1 ديسمبر 2023

A Case of Alopecia Areata Following Alemtuzumab in a Patient with Multiple Sclerosis
This case report details a 33-year-old male with relapsing-remitting multiple sclerosis who developed alopecia areata in his beard two years after his second alemtuzumab cycle. While alemtuzumab is known for triggering secondary autoimmune conditions, alopecia areata remains a rare and delayed side effect. Infectious and autoimmune causes were ruled out, and the condition was confirmed by a dermatologist. Treatment with local steroids showed partial improvement. This case adds to the growing evidence of delayed autoimmune manifestations linked to alemtuzumab therapy.